Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Advanced GIST After Failure of Standard Therapies
NCT07096609Phase 2Recruiting
- Sponsor
- Asan Medical Center
- Start
- Oct 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in gastrointestinal stromal tumor (GIST), sponsored by Asan Medical Center. Started Oct 2025; status: recruiting.
02
Drugs
lenvatinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT07096609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07096609.